Compare Stocks

→ READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTCY Biotricity	$1.37 +2.2%	$1.27	$0.70 ▼ $4.45	$12.91M	1.51	85,191 shs	69,276 shs
GCTK GlucoTrack	$0.53	$0.41	$0.13 ▼ $0.99	$14.30M	0.29	185,968 shs	93,550 shs
OSA ProSomnus	$0.10	$0.53	$0.35 ▼ $5.25	$8.18M	0.21	65,686 shs	3,075 shs
PETV PetVivo	$0.80 -3.6%	$0.95	$0.33 ▼ $2.90	$13.42M	2.08	53,281 shs	30,031 shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTCY Biotricity	+2.24%	-1.44%	-4.20%	+48.95%	+136,999,900.00%
GCTK GlucoTrack	-0.11%	+11.57%	+63.38%	+159.54%	+53.70%
OSA ProSomnus	-28.57%	-37.44%	-82.61%	-87.54%	-98.05%
PETV PetVivo	-3.50%	+1.50%	-20.00%	-37.50%	-66.80%

The biggest energy story ever? (Ad)

Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…

For the full story, click here.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GCTK GlucoTrack	0.7311 of 5 stars	0.0	3.0	0.0	0.0	3.7	2.5	0.0
OSA ProSomnus	1.6416 of 5 stars	3.3	5.0	0.0	0.0	0.0	1.7	0.0
PETV PetVivo	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTCY Biotricity	2.00	Hold	N/A	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A
OSA ProSomnus	2.67	Moderate Buy	$2.33	2,233.33% Upside
PETV PetVivo	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTCY Biotricity	$9.64M	1.34	N/A	N/A	($2.27) per share	-0.60
GCTK GlucoTrack	N/A	N/A	N/A	N/A	$0.15 per share	N/A
OSA ProSomnus	$27.65M	0.06	N/A	N/A	($2.33) per share	-0.04
PETV PetVivo	$920K	14.58	N/A	N/A	$0.07 per share	11.43

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTCY Biotricity	-$18.66M	-$1.39	N/A	N/A	N/A	-125.43%	N/A	-233.67%	7/4/2024 (Estimated)
GCTK GlucoTrack	-$7.10M	-$0.37	N/A	∞	N/A	N/A	-172.38%	-127.42%	5/10/2024 (Estimated)
OSA ProSomnus	-$24.09M	-$1.56	N/A	∞	N/A	-87.14%	N/A	-106.30%	5/10/2024 (Estimated)
PETV PetVivo	-$8.72M	-$0.86	N/A	∞	N/A	-1,016.64%	-1,319.59%	-299.92%	7/4/2024 (Estimated)

Latest PETV, GCTK, BTCY, and OSA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
3/28/2024	Q4 2023	GCTK GlucoTrack	N/A	-$0.10	-$0.10	-$0.10	N/A	N/A
2/20/2024	Q3 2024	BTCY Biotricity	-$0.41	-$0.34	+$0.07	-$0.34	$3.00 million	$2.97 million
2/12/2024	Q3 2024	PETV PetVivo	N/A	-$0.12	-$0.12	-$0.12	N/A	$0.60 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A
GCTK GlucoTrack	N/A	N/A	N/A	N/A	N/A
OSA ProSomnus	N/A	N/A	N/A	N/A	N/A
PETV PetVivo	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTCY Biotricity	N/A	0.21	0.10
GCTK GlucoTrack	0.06	3.22	3.22
OSA ProSomnus	N/A	1.00	0.86
PETV PetVivo	0.02	0.90	0.62

Ownership

Institutional Ownership

Company	Institutional Ownership
BTCY Biotricity	3.89%
GCTK GlucoTrack	10.92%
OSA ProSomnus	70.03%
PETV PetVivo	24.55%

Insider Ownership

Company	Insider Ownership
BTCY Biotricity	20.46%
GCTK GlucoTrack	17.70%
OSA ProSomnus	7.70%
PETV PetVivo	20.10%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BTCY Biotricity	55	9.42 million	7.49 million	Optionable
GCTK GlucoTrack	6	26.76 million	22.02 million	Not Optionable
OSA ProSomnus	136	17.39 million	16.06 million	Not Optionable
PETV PetVivo	25	16.77 million	13.40 million	Not Optionable

PETV, GCTK, BTCY, and OSA Headlines

Source	Headline
	Petvivo enacts cost cuts, executives take salary reductions investing.com - April 24 at 9:39 PM
	PetVivo Holdings CEO acquires $90k in company stock investing.com - April 19 at 8:02 AM
	PetVivo Holdings, Inc. (NASDAQ:PETV) CEO Buys $90,000.00 in Stock insidertrades.com - April 18 at 6:49 AM
	PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA globenewswire.com - April 8 at 6:30 AM
	PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA globenewswire.com - April 3 at 9:25 AM
	AT&T’s CFO on how the company saved $6 billion—and is planning to scrimp another $2 billion by 2026 fortune.com - March 15 at 10:16 AM
	SmallCapVoice.com Inc. (“SCV”) to Host First Annual Safety Summit featuring Up-and-Coming Public Companies globenewswire.com - March 14 at 2:01 PM
	PetVivo terminates ATM sales agreement with ThinkEquity msn.com - March 11 at 3:08 PM
	PetVivo Holdings Names Garry Lowenthal CFO markets.businessinsider.com - March 11 at 10:08 AM
	Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer globenewswire.com - March 11 at 8:00 AM
	New to The Street Announces its Five Corporate TV Interviews, Airing Episode 561 on the FOX Business Network Monday, March 11, 2024, at 10:30 PM PT finance.yahoo.com - March 8 at 12:23 PM
	PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV finance.yahoo.com - March 5 at 9:09 AM
	Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California globenewswire.com - February 29 at 8:00 AM
	PetVivo Holdings, Inc. Approved to Dual List on Upstream finance.yahoo.com - February 27 at 9:28 AM
	PetVivo reports revenue growth and net loss reduction in Q3 investing.com - February 15 at 12:21 AM
	PetVivo Holdings: Results Of Operations And Financial Condition, Financial Statements And Exhibits cbonds.com - February 14 at 9:20 AM
	PetVivo Holdings Third Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023) finance.yahoo.com - February 14 at 9:20 AM
	PetVivo Holdings, Inc. (NASDAQ:PETV) Q3 2024 Earnings Call Transcript finance.yahoo.com - February 13 at 1:17 PM
	PetVivo Holdings, Inc.: PetVivo Reports Third Quarter of Fiscal 2024 Financial Results finanznachrichten.de - February 13 at 8:17 AM
	PetVivo Reports Third Quarter of Fiscal 2024 Financial Results finance.yahoo.com - February 12 at 5:16 PM
	PetVivo Holdings Initiates New Financial Obligation msn.com - February 10 at 10:08 AM
	PetVivo Holdings Strikes Key Investment Agreements msn.com - February 8 at 3:06 PM
	PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024 finance.yahoo.com - February 7 at 3:32 PM
	PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy finance.yahoo.com - February 7 at 3:32 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Biotricity

NASDAQ:BTCY

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

GlucoTrack

NASDAQ:GCTK

GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

ProSomnus

NASDAQ:OSA

ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.

PetVivo

NASDAQ:PETV

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial